Fosravuconazole L-Lysine Ethanolate
N/A
Report date: 2026/03/30 17:02:26
Base Information
Drug NameFosravuconazole L-Lysine Ethanolate
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2018/01/19
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEisai Co LtdBristol-Myers Squibb Company
China Registration ClassN/A
Develop Information
Active CompaniesSato Pharmaceutical Co LtdSato Pharmaceutical Ltd
Inactive CompaniesEisai Co Ltd
Active Indications
Inactive Indications
Other Information
ATC Code
Related LinksKEGG